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INTRODUCTION
It is important to maintain bone health as the bone plays a role
in mechanical support, calcium storage, and RBC production.
Accordingly, a variety of methods have been investigated
for the restoration of bone defects in the oral and maxillofa-
cial regions.
1
Biomaterials containing additional bone growth factors or BMP
(bone morphogenic protein), including autogenous graft
bone, or ceramics, are currently being used for the restoration
of bone defects.
2 Various substitutes are also being used,
including mineralized frozen dried allograft, demineralized frozen
dried allograft, coralline calcium carbonate, polylactide-
polyglycolide copolymer, synthetic polymers, calcium sulfate,
bovine bone, and hydroxyapatite.
3
Bio-Oss
� (Geistlich, Wolhusen, Switzerland), an inorganic
material produced from bovine bone treated with ethylenediamine
and sterilized to remove organic materials such as protein, fol-
lowed by sterilization, consists of calcium-deficient carbon-
ate apatite. It has been used to fill any bone defect in the cran-
iofacial and periodontal regions for a long time. It was report-
ed that Bio-Oss
� has not only superior biocompatibility but also
can be sufficiently used as a scaffold for osteogenesis and
osteogenic cells.
1,4,5 However, it is known, that Bio-Oss
� has
poor osteoinduction. In addition, it was reported, that Bio-Oss
�
shows lower proliferation and differentiation of osteoblasts com-
pared to the other substitutes.
6,7
Three important factors have been proposed as prerequisites
for the stable treatment of the bone defect in the recent den-
tal implanting: soluble molecular signals, response cells with
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PURPOSE. This study was performed to investigate the ability of recombinant human-bone morphogenic protein-2 immobilized on a
heparin-grafted bone substrate to enhance the osteoblastic functions. MATERIALS AND METHODS. The Bio-Oss
�, not coated with any
material, was used as a control group. In rhBMP-2-Bio-Oss
� group, rhBMP-2 was coated with Bio-Oss
� using only deep and dry methods (50
ng/mL, 24 h). In heparinized rhBMP-2-Bio-Oss
� group, dopamine was anchored to the surface of Bio-Oss
�, and coated with heparin. rhBMP-
2 was immobilized onto the heparinized- Bio-Oss
� surface. The release kinetics of the rhBMP-2-Bio-Oss
� and heparinized rhBMP-2-Bio-Oss
� were
analyzed using an enzyme-linked immunosorbent assay. The biological activities of the MG63 cells on the three groups were investigated via
cytotoxicity assay, cell proliferation assay, alkaline phosphatase (ALP) measurement, and calcium deposition determination. Statistical
comparisons were carried out by one-way ANOVA test. Differences were considered statistically significant at *P<.05 and **P<.001.
RESULTS. The heparinized rhBMP-2-Bio-Oss
� showed more sustained release compared to the rhBMP-2-Bio-Oss
� over an extended time.
In the measurement of the ALP activity, the heparinized group showed a significantly higher ALP activity when compared with the non-heparinized
groups (P<.05). The MG63 cells cultivated in the group with rhBMP-2 showed increased calcium deposition, and the MG63 cells from the heparinized
group increased more than those that were cultivated in the non-heparinized groups. CONCLUSION. Heparin increased the rhBMP-2 release
amount and made sustained release possible, and heparinized Bio-Oss
� with rhBMP-2 successfully improved the osteoblastic functions.
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corresponding cell surface receptors, and the extracellular
matrix.
8,9 The molecular mechanism of such regeneration is
caused by osteogenic proteins that belong to the TGF-β
(transforming growth factor β ) subgroup. Among those pro-
teins, BMP has particularly drawn attention as a potent mate-
rial inducing bone differentiation.
10 There are more than 20 BMP
subgroups, among which BMP-2 has been proven via preclinical
and clinical studies to be useful for therapeutic purposes
regarding to bone graft in dentistry.
11,12 BMP-2 promotes the
proliferation of osteoblasts from mesenchymal stem cells by
regulating the essential factors for the osteoinduction-regen-
erating bone structure, and enhances osteogenesis by assisting
the biosynthesis of the bone matrix.
13 Sykaras et al.
14 report-
ed that BMP-2 was effective in titanium implant osseointegration.
Despite the successful use of BMP-2 in the enhancement of bone
regeneration, BMP-2 has the disadvantages of high cost,
need of large amount (1 mg BMP-2/mL defect), and short half-
life in the body.
15 To overcome the aforementioned prob-
lems, studies on the continuous and local release of BMP-2 using
collagen gels, sponges, scaffolds, hyaluronic acid, and fibrin
gels have been conducted.
16-23 Such methods have various
problems, however, such as failure in regulating the release
amount, early and short-term release.
24
In this study, heparin was used to regulate rhBMP-2 release.
Heparin, which is a highly sulfationized linear natural poly-
saccharide, has been known to have a binding affinity with var-
ious growth factors, such as the vascular endothelial growth
factor (VEGF), basic fibroblast growth factor (bFGF), and trans-
forming growth factor-β(TGF-β ).
25 Furthermore, heparin
has been reported to regulate the release of such growth fac-
tors.
26,27 Many studies reported that the binding of BMP-2
with heparin on a titanium surface resulted in the continuous
release of BMP-2 which resulted in an anti-inflammatory response
and the reinforced function of the osteoblast-like cells.
28-31
A study reported that the bone deposition and the amount of
bone growth after six weeks implantation were higher in the
BMP-2-coated implants than in the non-BMP-2-coated
implants in the bone defects in rabbits. This effect was clear-
ly reinforced by the surface modification of heparin.
28 The sur-
face modification of heparin by a collagen matrix enabled the
long-term release of BMP-2 in a biomimetic model. In addi-
tion, the binding of rhBMP-2 and heparin on the thin apatite
surface of the titanium which was suspended in the simulat-
ed body fluid after the base and heat treatments seemed to stim-
ulate both the ALP activity and the expression of OCN
mRNA in the osteoblast-like cells.
29
Accordingly, in this study, the surface of the Bio-Oss
�
bone substitute was modified with heparin and then was
coated with rhBMP-2. Subsequently, a method that promotes
osteoinduction for bone formation was explored, and its
validity was assessed on a cellular level.
MATERIALS AND METHODS
Immobilization of rhBMP-2 on the heparinized Bio-Oss
� �
The Bio-Oss
�, not coated with any material, was used as a
control group. In rhBMP-2-Bio-Oss
� group, rhBMP-2
(Cowellmwdi Co., Pusan, South Korea) was coated with
Bio-Oss
� using deep and dry methods (50 ng/mL, 24 h). In
heparinized rhBMP-2-Bio-Oss
� group, to immobilize rhBMP-
2 on the surface of the Bio-Oss
�, the Bio-Oss
� surface was coat-
ed with heparinized dopamine in advance. 2 mg/mL heparinized
dopamine was dissolved in a 10 mM Tris-HCl (pH 8.0)
buffer, and then 100 mg Bio-Oss
� was put into the Tris-HCl
buffer solution, followed by reaction under blocked light for
24 h. After the reaction, the Bio-Oss
� was washed with distilled
water, freeze-dried, and then 50 ng/mL rhBMP-2 was immo-
bilized on the heparinized Bio-Oss
�. The heparinized Bio-Oss
�
(100 mg) was then put into a 0.1M MES (pH 5.6) buffer, and
rhBMP-2 (50 ng/mL) was added to the buffer, followed by reac-
tion at room temperature for 24 h.
Assessment of the morphological characteristics of
Bio-Oss
� �
The Bio-Oss
�, rhBMP-2-Bio-Oss
�, and heparinized rhBMP-
2-Bio-Oss
� were morphologically analyzed using a scan-
ning electron microscope (SEM; S2300, Hitachi, Tokyo,
Japan). The samples were coated with Pt using a sputter-
coater (Eiko IB, Tokyo, Japan). The SEM was accelerated with
10 kV power before use.
Release kinetics of rhBMP-2 
Each sample of rhBMP-2-Bio-Oss
� and heparinized rhBMP-
2-Bio-Oss
� was put into an E-tube containing 1 mL PBS
(pH 7.4) 0.02% sodium azide. Then the samples were react-
ed in an agitating incubator with 100 rpm, at 37℃. The
supernant was collected in a specified interval and was
replaced with a new buffer. The amount of BMP-2 in the col-
lected supernatant was measured using an ELISA development
kit (Pepro Tech, Rocky Hill, NJ, USA) in a microplate read-
er, at 495 nm.
Cell culture
Aliquots of human-derived MG63 osteoblast-like cells
(KCLB, Seoul, South Korea) in Dulbecco’ s Modified Eagle’ s
Medium (DMEM), with added 10% fetal bovine serum (FBS,
Gibco BRL, Grand Island, NY, USA), 100 U/mL penicillin,
and 100 μ g/mL streptomycin were loaded onto a 100-mm cul-
ture plate. They were cultured at 37℃ and 100% humidity while
continuously supplying 95% air and 5% CO2. For the induc-
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tion of osteogenic differentiation, they were cultured in
DMEM (osteogenic medium) containing 100 U/mL peni-
cillin, 100 μ g/mL streptomycin, and 10% FBS, with addition
of 100 nM dexamethasone, 100 μ M ascorbic acid, and 10 mM
β -glycerolphosphate.
Assessment of cytotoxicity
MG63 osteoblast-like cells were loaded onto a 24-tran-
swell culture plate containing Bio-Oss
�, rhBMP-2-Bio-Oss
�,
and heparinized rhBMP-2-Bio-Oss
�, respectively, to have an
aliquot of 5×10
4 cells in each plate. After culturing at 37℃ for
24 and 48 h, respectively, the plate was treated with CCK-8
(Dojindo, Tokyo, Japan) reagent for 1 h to assess the cytotox-
icity of the samples. The culture media that was treated with
the reagent was transferred into a 96-well plate, and its
absorbance was measured with a microplate reader at 450 nm.
Each group was cultured three times, according to time.
Measurement of cell proliferation
MG63 osteoblast-like cells were loaded onto a 24-tran-
swell culture plate containing Bio-Oss
�, rhBMP-2-Bio-Oss
�,
and heparinized rhBMP-2-Bio-Oss
�, respectively, to have an
aliquot of 5×10
4 cells in each plate. After culturing at 37℃ for
1, 3, and 7 days, respectively, the plate was treated with
CCK-8 (Dojindo, Tokyo, Japan) reagent for 1 h to assess
the cell proliferation of the samples. The culture media that was
treated with the reagent was transferred into a 96-well plate,
and its absorbance was measured with a microplate reader at
450 nm. Each group was cultured three times, according to time.
Measurement of alkaline phosphatase activity
MG63 osteoblast-like cells were loaded onto a 24-tran-
swell culture plate containing Bio-Oss
�, rhBMP-2-Bio-Oss
�,
and heparinized rhBMP-2-Bio-Oss
�, respectively, to have
an aliquot of 5×10
4 cells in each plate. Then the plate was cul-
tured in DMEM culture media containing 100 U/mL penicillin,
100 μ g/mL streptomycin, and 10% FBS, to which 100 nM dex-
amethasone, 100 μ M ascorbic acid, and 10 mM β -glyc-
erolphosphate were added for 7, 14, and 21 days, respectively.
After culturing, the media was removed, and the cells were sep-
arated with trypsin-EDTA, followed by collection via cen-
trifugation. The supernatant was removed, after which 0.2 mL
RIPA buffer solution was added. The solution was suspend-
ed using a sonicator, and the cells were dissolved at 4℃.
The dissolved cells were centrifuged, and p-nitrophenyl phos-
phate (p-NPP) solution was then added to the supernatant, fol-
lowed by reaction for 30 min. Then the reaction was halted by
adding 1N NaOH. The hydrolysis of p-NPP was measured with
a microplate reader at 410 nm, and p-nitrophenol (p-NP)
was used as a standard value. The protein concentration was
measured using a Bradford protein assay reagent, and bovine
serum albumin was used as a standard. The ALP activity
was denoted as μ M/min/μ g protein. In each experiment, the activ-
ity was calculated as a percentage over the negative con-
trol. Each experiment was conducted three times.
Measurement of calcium accumulation
Human-derived MG63 osteoblast-like cells were loaded
onto a 6-transwell culture plate containing Bio-Oss
�, rhBMP-
2-Bio-Oss
�, and heparinized rhBMP-2-Bio-Oss
�, respec-
tively, to have an aliquot of 1×10
5 cells in each plate, followed
by culturing for 21 days. After 21-day culturing, the media was
removed, and the cells were washed with PBS. The cells
were fixed in ice-cold 70% ethanol at -20℃ for 1 h. After remov-
ing the ethanol, the cells were stained with Alizarin red S (pH
4.2) at room temperature for 10 min. Alizarin red S was
then removed, and the cells were washed with distilled water
three times. The stained parts were photographed using an opti-
cal microscope (Olympus, Tokyo, Japan) for comparative
analysis.
Statistical analysis
All the data were denoted as mean±SD. Statistical analy-
sis was conducted using t test and one-way analysis of variance
(ANOVA, Systat Software, Inc.) to determine the signifi-
cance levels of the cytotoxicity, cell proliferation, and ALP activ-
ity for each sample (*P<.05, **P<.001).
RESULTS
Observation of the surface morphology of the Bio-Oss
� �
The surfaces of the Bio-Oss
�, rhBMP-2-Bio-Oss
�, and
heparinized rhBMP-2-Bio-Oss
� were compared by SEM to
observe their microstructures (Fig. 1). No difference in surface
morphology was found.
Release kinetics of recombinant human-bone morpho-
genetic protein-2 (rhBMP-2)
When the release kinetics of rhBMP-2 were observed in the
rhBMP-2-Bio-Oss
� and heparinized rhBMP-2-Bio-Oss
�,
rhBMP-2 was rapidly released in the rhBMP-2-Bio-Oss
�
group at an early stage. Meanwhile, more rhBMP-2 was
released in the heparinized rhBMP-2-Bio-Oss
� group than in
the rhBMP-2-Bio-Oss
� group. Furthermore, rhBMP-2 was con-
tinuously released during the two-week period, and approxi-
mately 20% of the original amount of rhBMP-2 seemed to be
released after the two-week period, showing a tendency of con-
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tinuous release. Therefore, rhBMP-2 was slowly and contin-
uously released in the heparinized rhBMP-2-Bio-Oss
� with the
passage of time (Fig. 2).
Assessment of cytotoxicity and cell proliferation
When the cytotoxicity of the three Bio-Oss
� groups was
assessed, no cytotoxicity was found in the three groups when
compared to the control group, where only MG63 cells were
cultured for 24 and 48 h (Fig. 3). When MG63 cells were cul-
tured in the Bio-Oss
�, rhBMP-2-Bio-Oss
�, and heparinized
rhBMP-2-Bio-Oss
� for 1, 3, and 7 days, and the cell proliferation
was observed, no significant difference was found (Fig. 4).
Measurement of alkaline phosphatase activity
When the ALP activity, which is a marker of the differentiation
of osteoblast-like cells, was measured, the activity increased
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Fig. 1. SEM images of the (A) Bio-Oss
�, (B) rhBMP-2 (50 ng/ml)-Bio-Oss
�, and (C) heparinized rhBMP-2 (50 ng/ml)-Bio-Oss
�.
A C B
Fig. 2. Release kinetics of the rhBMP-2-(50 ng)-Bio-Oss
� and heparinized
rhBMP-2-(50 ng)-Bio-Oss
�.
Fig. 3. Cytotoxicity of the osteoblast-like cells (MG63 cells) grown on
the Bio-Oss
�, rhBMP-2-(50 ng)-Bio-Oss
�, and heparinized rhBMP-2-
(50 ng)-Bio-Oss
�.
Fig. 4. Proliferation of the osteoblast-like cells (MG63 cells) grown on
the Bio-Oss
�, rhBMP-2-(50 ng)-Bio-Oss
�, and heparinized rhBmp-2-
(50 ng)-Bio-Oss
�.
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in the MG63 osteoblast-like cells which were cultured in
the Bio-Oss
� groups with rhBMP-2 (*P<.05) on day 7 after
culture. The ALP activity increased more in the MG63
osteoblast-like cells cultured in the heparinized rhBMP-2-Bio-
Oss
� than in those cultured in the control and non-heparinized
groups, which showed a significant difference on day 14
after culture (**P<.001). In addition, the ALP activity reached
its peak in all three groups on day 14 after culture, and
decreased in all three groups on day 21 after culture when com-
pared to those of 14 (Fig. 5).
Assessment of calcium accumulation (Alizarin red S) 
The accumulation of calcium, an inorganic material that was
deposited on the bone during ossification, was observed on day
31 after culture, calcium accumulation increased in the MG63
osteoblast-like cells cultured in the Bio-Oss
� groups with
rhBMP-2. Furthermore, calcium accumulation increased
more in the MG63 osteoblast-like cells that were cultured in
the heparinized group than in those that were cultured in the
control and non-heparinized groups (Fig. 6). Therefore, it
was confirmed that the heparinized substitute had a superior
osteogenic ability.
DISCUSSION
When autogenous graft bone or other bone substitutes are used
for bone transplantation, the new bone is formed through
osteoconduction, osteogenesis, and osteoinduction.
Osteoconduction is defined as the induction of bone formation
in which bone substitutes act as a scaffold for bone formation.
Osteogenesis is caused by bone-forming cells and a matrix direct-
ly provided from bone substitutes. Osteoinduction refers to the
induction of osteoblast differentiation undifferentiated mes-
enchymal cells after the chemotaxis of substitutes on the
undifferentiated mesenchymal cells in the host. BMP is asso-
ciated with osteoinduction.
32
Bio-Oss
� has been reported not only to have superior bio-
compatibility but also to be sufficiently used as a scaffold of
osteogenesis and osteogenic cells, but it is known to have poor
osteoinduction.
1,4,5 Accordingly, the use of rhBMP-2 for over-
coming the aforementioned problem has been investigated.
As a growth factor with the best osteoinduction ability,
rhBMP-2 has been intensively investigated, but its application
to clinical practice was restricted due to its short half-life, rapid
dissolution by body fluid, large-amount requirement, and
high production cost. In this study, rhBMP-2 from E. coli
(Escherichia coli) was used. RhBMP-2 can be produced on a
large scale, unlike the BMP produced from the CHO cell
used in previous studies. Therefore, rhBMP-2 has the advan-
tages of cost-saving and mass production. Bessho et al.
33
reported that when the aforementioned two rhBMP-2 were used,
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Fig. 6. Alizarin-red-S staining of the osteoblast-like cells (MG63 cells) grown on the Bio-Oss
� (A), rhBMP-2-(50 ng)-Bio-Oss
� (B), and heparinized
rhBMP-2 (50 ng)-Bio-Oss
� (C) after 21-day incubation (scale bar = 20 μ m).
A C B
Fig. 5. ALP activity of the osteoblast-like cells (MG63 cells) grown on
the Bio-Oss
�, rhBMP-2-(50 ng)-Bio-Oss
�, and heparinized rhBMP-2-
(50 ng)-Bio-Oss
� after 7-, 14-, and 21-day incubation.
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lower bone density was obtained from the rhBMP-2 pro-
duced from E. coli, and fatty marrow was formed. The efficacy
and safety of the E. coli-derived rhBMP-2 (Cowellmwdi
Co., Pusan, South Korea) used in this study, has been proven
in many studies.
34,35
For the establishment of an effective rhBMP-2 application
system and an appropriate rhBMP-2 release amount for a
sufficient period, the surface of Bio-Oss
� was modified with
heparin in this study, followed by the immobilization of
rhBMP-2 on the surface. rhBMP-2 was successfully released
from the heparinized rhBMP-2-Bio-Oss
� for an extended
period. The continuous release of growth factors, including var-
ious types of matrices, from heparin has been reported in many
studies.
27,36,37 Lin et al.
37 reported that in an in vivo experiment,
the ALP activity and calcified-tissue rate increased in the
cells attached to the demineralized bone matrix, where heparin
was crossly bound for the binding of rhBMP-2. From the results
of the aforementioned studies, heparin can be considered as a
suitable for the continuous release of growth factors material.
In this study, cell proliferation increased more in the MG63
cells cultured in the rhBMP-2-immobilized groups than in those
cultured in the groups without rhBMP-2, but the increase
was not significant. On the contrary, Park et al.
38 reported that
cell proliferation significantly increased in the osteoblast-
like cells cultured in the nanofibrous chitosan membrane
with immobilized rhBMP-2 than in those cultured in the
nanofibrous chitosan membrane without rhBMP-2. Therefore,
it seems that the effect of rhBMP-2 on the proliferation of
osteoblast-like cells is unclear.
ALP activity and calcium accumulation have been widely used
as markers of the early and late differentiation of osteoblast-
like cells.
39,40 ALP activity was measured on days 7, 14, and 21
after culture. No significant difference in cell proliferation was
found between the groups with immobilized rhBMP-2 and those
without immobilized rhBMP-2. Meanwhile, the ALP activi-
ty was significantly higher in the groups with immobilized
rhBMP-2 than in those without immobilized rhBMP-2 during
the various culturing periods. Therefore, rhBMP-2 stimulat-
ed the differentiation of osteoblast-like cells. The ALP activ-
ity in all the matrices, however, was reduced slightly more on
day 21 than on day 14. This means that the ALP activity reached
the peak prior to the actual initiation of calcification.
41
Furthermore, the aforementioned result showed that the ALP
activity gradually decreased beyond day 14, whereas the
calcium accumulation gradually increased. When the calcium
accumulation was measured on day 21 after culture, it was
increased in the MG63 osteoblast-like cells that were cultured
in the groups with immobilized rhBMP-2, and increased
more in the MG63 osteoblast-like cells that were cultured in
the heparinized group than in those that were cultured in the
non-heparinized group. The aforementioned results showed that
the heparinized rhBMP-2-Bio-Oss
� stimulated matrix formation
and enhanced the functions of the osteoblast-like cells.
In this study, the reactions were investigated on a cellular lev-
el. Therefore, the results of this study should be validated through
animal experiments and clinical studies. Furthermore, considering
the current unclear rhBMP-2 concentration standard, further
studies are required to determine the optimal concentration and
amount of rhBMP-2 in combined use with Bio-Oss
�, via
the application of rhBMP-2 with various concentrations.
CONCLUSION
When Bio-Oss
� was treated with heparin and rhBMP-2
was then immobilized on the heparinized surface, Bio-Oss
�
showed successful functional improvement. Heparin increased
the rhBMP-2 release amount and allowed sustained release. The
heparinized rhBMP-2-Bio-Oss
� successfully improved the
osteoblastic functions.
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